Cocrystal Pharma Inc. logo

Cocrystal Pharma Inc.

COCP | NASDAQ
Chart Builder DCF Calculator
$1.22
+$0.01 (+0.83%)
At close: Sep 21, 2026, 3:59 PM ET
$1.19
-$0.03 (-2.46%)
After-hours: Sep 21, 2026, 4:10 PM ET

Market Data

Market Cap
$16.68M
Enterprise Value
$15.92M
Beta
1.48
Average Volume
89.52K
Shares Outstanding (Diluted)
13.79M
Shares Change YoY
35.52%
Institutional Ownership
5.63%
Exchange
NASDAQ
ISIN
US19188J4094

Price Performance

Price Change 1M
2.5%
Price Change 3M
15.1%
Price Change 6M
13.0%
Price Change YTD
22.9%
Price Change 1Y
-6.2%
Price Change 3Y
-35.8%
Price Change 5Y
-90.1%
1M CAGR (ann.)
17.5%
1Y CAGR (ann.)
-0.8%
5Y CAGR (ann.)
-37.9%
All-Time CAGR
-36.5%

Valuation

PE Ratio
-1.58
Forward PE
N/A
PEG Ratio
-0.03
Forward PEG
0.10
PS Ratio
50.76
Forward PS
N/A
PB Ratio
16.05
P/FCF Ratio
-2.05
P/Adj. FCF Ratio
-2.00
P/OCF Ratio
-2.07
EV/Sales
48.25
EV/EBIT
-1.60
EV/EBITDA
-1.68
EV/FCF
-1.95
Earnings Yield
-63.1%
FCF Yield
-48.7%
Adj. FCF Yield
-50.1%

Financial Health

Net Cash
$2.17M
Total Debt
$1.34M
Cash & Short-Term Investments
$2.17M
Total Assets
$4.65M
Current Ratio
1.24
Quick Ratio
1.24
Debt / Equity Ratio
1.28
Debt / EBITDA
-0.14
Debt / FCF
-0.16
OCF / Debt
-6.07
Interest Coverage
0.00
Altman Z-Score
-108.76
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
205.8%
Operating Profit Margin
-3063.6%
EBITDA Margin
-2876.7%
Net Profit Margin
-3011.5%
FCF Margin
-2470.7%
Adj. FCF Margin
-2541.0%
SBC / Revenue
70.3%
SBC Impact (per share)
-2.9%

Returns

Return on Assets
-213.8%
Return on Equity
-207.5%
Return on Invested Capital
-423.9%
Return on Capital Employed
-497.3%
Return on Tangible Assets
-213.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
150.0%
Revenue CAGR 5Y
-19.9%
Revenue CAGR 10Y
-21.8%
EPS CAGR 3Y
39.7%
EPS CAGR 5Y
51.9%
EPS CAGR 10Y
30.3%
FCF CAGR 3Y
25.6%
FCF CAGR 5Y
16.7%
FCF CAGR 10Y
-7.7%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-8.14M
Free Cash Flow
$-8.15M
Adj. Free Cash Flow
$-8.39M
FCF Per Share
-$0.59
OCF Per Share
-$0.59
OCF/S Ratio
-2466.9%

Income Statement

Revenue
$330K
Gross Profit
$679K
Operating Income
$-10.11M
EBITDA
$-9.49M
Net Income
$-9.94M
EPS (Diluted)
-$0.77
Revenue / Employee
$33K
Profit / Employee
$-993.8K
Employees
10

© 2026 bestshares.com. All rights reserved.